Julia Bijok1,2, Sylwia Dąbkowska3, Anna Kucińska-Chahwan4, Diana Massalska3,5, Beata Nowakowska4, Sylwia Gawlik-Zawiślak6, Grzegorz Panek3,5, Tomasz Roszkowski3,5. 1. Department of Gynecologic Oncology and Obstetrics, Professor Witold Orlowski Public Teaching Hospital, Warsaw, Poland. julia.bijok@gmail.com. 2. Department of Gynecologic Oncology and Obstetrics, Centre of Postgraduate Medical Education, ul. Czerniakowska 231, 00413, Warsaw, Poland. julia.bijok@gmail.com. 3. Department of Gynecologic Oncology and Obstetrics, Professor Witold Orlowski Public Teaching Hospital, Warsaw, Poland. 4. Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland. 5. Department of Gynecologic Oncology and Obstetrics, Centre of Postgraduate Medical Education, ul. Czerniakowska 231, 00413, Warsaw, Poland. 6. Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.
Abstract
OBJECTIVES: To analyse additional structural and genetic anomalies in fetuses with acrania/exencephaly/anencephaly sequence (AEAS). METHODS: A retrospective analysis of 139 fetuses with AEAS diagnosed between 2006 and 2020 in a single tertiary referral ultrasound department. RESULTS: The median gestational age at diagnosis decreased from 15 weeks in 2006 to 13 weeks in 2020 (- 0.21 per each year; p = 0.009). In 103 fetuses, the defects were limited to the neural tube (NTD) (74.1%), in 36 fetuses (25.9%), there were additional structural non-NTD anomalies. The most common were ventral body wall defects present in 17.8% (23/139), followed by anomalies of the limbs (7.2%; 10/139), face (6.5%; 9/139) and heart (6.5%; 9/139). Genetic anomalies were diagnosed in 7 of the 74 conclusive results (9.5%; 7/74; trisomy 18, n = 5; triploidy, n = 1; duplication of Xq, n = 1). In univariate logistic regression models, male sex, limb anomalies and ventral body wall defects significantly increased the risk of genetic anomalies (OR 12.3; p = 0.024; OR 16.5; p = 0.002 and OR 10.4; p = 0.009, respectively). CONCLUSIONS: A significant number of fetuses with AEAS have additional structural non-NTD anomalies, which are mostly consistent with limb body wall complex. Genetic abnormalities are diagnosed in almost 10% of affected fetuses and trisomy 18 is the most common aberration. Factors that significantly increased the odds of genetic anomalies in fetuses with AEAS comprise male sex, limb anomalies and ventral body wall defects.
OBJECTIVES: To analyse additional structural and genetic anomalies in fetuses with acrania/exencephaly/anencephaly sequence (AEAS). METHODS: A retrospective analysis of 139 fetuses with AEAS diagnosed between 2006 and 2020 in a single tertiary referral ultrasound department. RESULTS: The median gestational age at diagnosis decreased from 15 weeks in 2006 to 13 weeks in 2020 (- 0.21 per each year; p = 0.009). In 103 fetuses, the defects were limited to the neural tube (NTD) (74.1%), in 36 fetuses (25.9%), there were additional structural non-NTD anomalies. The most common were ventral body wall defects present in 17.8% (23/139), followed by anomalies of the limbs (7.2%; 10/139), face (6.5%; 9/139) and heart (6.5%; 9/139). Genetic anomalies were diagnosed in 7 of the 74 conclusive results (9.5%; 7/74; trisomy 18, n = 5; triploidy, n = 1; duplication of Xq, n = 1). In univariate logistic regression models, male sex, limb anomalies and ventral body wall defects significantly increased the risk of genetic anomalies (OR 12.3; p = 0.024; OR 16.5; p = 0.002 and OR 10.4; p = 0.009, respectively). CONCLUSIONS: A significant number of fetuses with AEAS have additional structural non-NTD anomalies, which are mostly consistent with limb body wall complex. Genetic abnormalities are diagnosed in almost 10% of affected fetuses and trisomy 18 is the most common aberration. Factors that significantly increased the odds of genetic anomalies in fetuses with AEAS comprise male sex, limb anomalies and ventral body wall defects.
Authors: L J Salomon; Z Alfirevic; V Berghella; C Bilardo; E Hernandez-Andrade; S L Johnsen; K Kalache; K-Y Leung; G Malinger; H Munoz; F Prefumo; A Toi; W Lee Journal: Ultrasound Obstet Gynecol Date: 2011-01 Impact factor: 7.299
Authors: J H Fleurke-Rozema; L van Leijden; K van de Kamp; E Pajkrt; C M Bilardo; R J M Snijders Journal: Prenat Diagn Date: 2015-05 Impact factor: 3.050
Authors: Sebastian Köhler; Marcel H Schulz; Peter Krawitz; Sebastian Bauer; Sandra Dölken; Claus E Ott; Christine Mundlos; Denise Horn; Stefan Mundlos; Peter N Robinson Journal: Am J Hum Genet Date: 2009-10 Impact factor: 11.025
Authors: Sebastian Köhler; Nicole A Vasilevsky; Mark Engelstad; Erin Foster; Julie McMurry; Ségolène Aymé; Gareth Baynam; Susan M Bello; Cornelius F Boerkoel; Kym M Boycott; Michael Brudno; Orion J Buske; Patrick F Chinnery; Valentina Cipriani; Laureen E Connell; Hugh J S Dawkins; Laura E DeMare; Andrew D Devereau; Bert B A de Vries; Helen V Firth; Kathleen Freson; Daniel Greene; Ada Hamosh; Ingo Helbig; Courtney Hum; Johanna A Jähn; Roger James; Roland Krause; Stanley J F Laulederkind; Hanns Lochmüller; Gholson J Lyon; Soichi Ogishima; Annie Olry; Willem H Ouwehand; Nikolas Pontikos; Ana Rath; Franz Schaefer; Richard H Scott; Michael Segal; Panagiotis I Sergouniotis; Richard Sever; Cynthia L Smith; Volker Straub; Rachel Thompson; Catherine Turner; Ernest Turro; Marijcke W M Veltman; Tom Vulliamy; Jing Yu; Julie von Ziegenweidt; Andreas Zankl; Stephan Züchner; Tomasz Zemojtel; Julius O B Jacobsen; Tudor Groza; Damian Smedley; Christopher J Mungall; Melissa Haendel; Peter N Robinson Journal: Nucleic Acids Res Date: 2016-11-28 Impact factor: 16.971